These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15040793)

  • 1. Consumer choice of social health insurance in managed competition.
    Kerssens JJ; Groenewegen PP
    Health Expect; 2003 Dec; 6(4):312-22. PubMed ID: 15040793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Dutch health insurance reform: switching between insurers, a comparison between the general population and the chronically ill and disabled.
    de Jong JD; van den Brink-Muinen A; Groenewegen PP
    BMC Health Serv Res; 2008 Mar; 8():58. PubMed ID: 18366678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the chronically ill population in the Netherlands switch their health insurer as often as the general population? Empirical evidence from a nationwide survey study.
    van der Schors W; Brabers AEM; De Jong JD
    BMC Health Serv Res; 2020 May; 20(1):376. PubMed ID: 32370798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choice of insurer for basic health insurance restricted by supplementary insurance.
    Duijmelinck DM; van de Ven WP
    Eur J Health Econ; 2014 Sep; 15(7):737-46. PubMed ID: 23887827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does supplementary health insurance play a role in the switching behaviour of citizens in the Netherlands?
    Holst L; Brabers A; de Jong J
    J Mark Access Health Policy; 2022; 10(1):2015863. PubMed ID: 34925712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switching benefits and costs in competitive health insurance markets: A conceptual framework and empirical evidence from the Netherlands.
    Duijmelinck DM; Mosca I; van de Ven WP
    Health Policy; 2015 May; 119(5):664-71. PubMed ID: 25530069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managed competition and consumer price sensitivity in social health insurance.
    Schut FT; Hassink WH
    J Health Econ; 2002 Nov; 21(6):1009-29. PubMed ID: 12475123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consumer price sensitivity in Dutch health insurance.
    van Dijk M; Pomp M; Douven R; Laske-Aldershof T; Schut E; de Boer W; de Boo A
    Int J Health Care Finance Econ; 2008 Dec; 8(4):225-44. PubMed ID: 18709549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advice from the health insurer as a channelling strategy: a natural experiment at a Dutch health insurance company.
    Bes RE; Curfs EC; Groenewegen PP; de Jong JD
    BMC Health Serv Res; 2018 Nov; 18(1):832. PubMed ID: 30400978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managed competition in the Netherlands-a qualitative study.
    Heinemann S; Leiber S; Gress S
    Health Policy; 2013 Feb; 109(2):113-21. PubMed ID: 23031431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The intention to switch health insurer and actual switching behaviour: are there differences between groups of people?
    Hendriks M; de Jong JD; van den Brink-Muinen A; Groenewegen PP
    Health Expect; 2010 Jun; 13(2):195-207. PubMed ID: 19906212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What health plans do people prefer? The trade-off between premium and provider choice.
    Determann D; Lambooij MS; de Bekker-Grob EW; Hayen AP; Varkevisser M; Schut FT; Wit GA
    Soc Sci Med; 2016 Sep; 165():10-18. PubMed ID: 27485728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptance of selective contracting: the role of trust in the health insurer.
    Bes RE; Wendel S; Curfs EC; Groenewegen PP; de Jong JD
    BMC Health Serv Res; 2013 Oct; 13():375. PubMed ID: 24083663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can premium differentiation counteract adverse selection in the Dutch supplementary health insurance? A simulation study.
    van Winssen KPM; van Kleef RC; van de Ven WPMM
    Eur J Health Econ; 2018 Jun; 19(5):757-768. PubMed ID: 28762051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free choice of sickness funds in regulated competition: evidence from Germany and The Netherlands.
    Gress S; Groenewegen P; Kerssens J; Braun B; Wasem J
    Health Policy; 2002 Jun; 60(3):235-54. PubMed ID: 11965333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assessment of the Dutch experience with health insurers acting as healthcare advisors.
    Victoor A; Brabers AEM; van Esch TEM; de Jong JD
    PLoS One; 2019; 14(11):e0224829. PubMed ID: 31703085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supplementary insurance as a switching cost for basic health insurance: Empirical results from the Netherlands.
    Willemse-Duijmelinck DMID; van de Ven WPMM; Mosca I
    Health Policy; 2017 Oct; 121(10):1085-1092. PubMed ID: 28855064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation between trust and the willingness of enrollees to receive healthcare advice from their health insurer.
    van der Hulst FJP; Brabers AEM; de Jong JD
    BMC Health Serv Res; 2023 Jan; 23(1):52. PubMed ID: 36653840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of supplementary health insurance on switching behaviour: evidence from Swiss data.
    Dormont B; Geoffard PY; Lamiraud K
    Health Econ; 2009 Nov; 18(11):1339-56. PubMed ID: 19267356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperation amongst insurers on enhancing quality of care: precondition or substitute for competition?
    Stolper KCF; Boonen LHHM; Schut FT; Varkevisser M
    Health Econ Policy Law; 2021 Jul; 16(3):273-289. PubMed ID: 32690116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.